Researchers assessed the effect of treatment with teriparatide on bone quality indices at trabecular surfaces in patients with postmenopausal osteoporosis.
Researchers assessed and compared the clinical efficacy of romosozumab in patients with rheumatoid arthritis osteoporosis and primary osteoporosis.
In a poster presented at ASBMR 2021, researchers compared fracture rates and treatment adherence in women with osteoporosis who received risedronate gastro-resistant vs oral immediate-release bisphosphonates.
In a plenary poster presentation at ASBMR 2021, researchers determined whether muscle strength and performance measures improved fracture risk prediction in men.
The labeling for Tymlos (abaloparatide) has been updated to include additional information regarding the mechanism of action.
No significant difference in SRE risk on the basis of intravenous bisphosphonate dosing was observed for patients with newly diagnosed multiple myeloma.
The network meta-analysis compared the effects of 9 osteoporosis drugs on BMD.
Researchers evaluated bone erosions and osteophytes in premenopausal women with long-standing rheumatoid arthritis.
One out of every 6 older hip fracture patients is still taking opioid pain medications 3 to 6 months after surgery.
NAMS publishes updated recommendations are presented for osteoporosis prevention and management in postmenopausal women.
